Actinium Pharmaceuticals, Inc.
SEC Filing List
ATNM CIK: 0001388320
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 10-K | Annual report pursuant to Section 13 and... | Actinium Pharmaceuticals, Inc. | EdgarAgents LLC /fa | 03/30/2026 | |
| 8-K/A | Amendment to Current report filing | Actinium Pharmaceuticals, Inc. | EdgarAgents LLC /fa | 03/26/2026 | |
| 8-K | Current report filing | Actinium Pharmaceuticals, Inc. | EdgarAgents LLC /fa | 02/13/2026 | |
| 8-K | Current report filing | Actinium Pharmaceuticals, Inc. | EdgarAgents LLC /fa | 11/26/2025 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Actinium Pharmaceuticals, Inc. | EdgarAgents LLC /fa | 11/14/2025 | |
| ARS | Annual report to security holders | Actinium Pharmaceuticals, Inc. | EdgarAgents LLC /fa | 11/05/2025 | |
| DEF 14A | Definitive proxy statements | Actinium Pharmaceuticals, Inc. | EdgarAgents LLC /fa | 11/05/2025 | |
| 4 | Statement of changes in beneficial owner... | Seth Sandesh | EdgarAgents LLC /fa | 08/20/2025 | |
| 10-Q | Quarterly report pursuant to Section 13 ... | Actinium Pharmaceuticals, Inc. | EdgarAgents LLC /fa | 08/08/2025 | |
| SCHEDULE 13G/A | VANGUARD HORIZON FUNDS /fa | 07/29/2025 | |||
| No record found. | |||||
| Load More | |||||
